Gli2 Expression and Human Bladder Transitional Carcinoma Cell Invasiveness

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 344-351

  Mechlin, Clay W ^a   Tanner, Matthew J ^c   Chen, Mengqian ^c   Buttyan, Ralph ^a,c   Levin, Robert M ^a,d   Mian, Badar M ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

^d ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

carcinoma, transitional cell; cyclopamine; gene expression; Gli2 protein; urinary bladder neoplasms

Indexed keywords

CYCLOPAMINE; GLIOMA ASSOCIATED ONCOGENE HOMOLOG 2 PROTEIN; MATRIGEL; RECEPTOR; RNA; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; LENTIVIRINAE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; DIOXOLES; GENE EXPRESSION PROFILING; HEDGEHOG PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LINEAR MODELS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PIPERAZINES; PYRIDINES; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOMATINE; URINARY BLADDER NEOPLASMS; VERATRUM ALKALOIDS;

EID: 77953119517     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.007     Document Type: Article

References (30)

1. Cancer Facts and Figures 2009. American Cancer Society®. http://www.cancer.org/downloads/STT/500809web.pdf Accessed December 8, 2009
2. Haraguchi R., Motoyama J., Sasaki H., et al. Molecular analysis of coordinated bladder and urogenital organ formation by Hedgehog signaling. Development 134 (2007) 525
3. Nusslein-Volhard C., and Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 287 (1980) 795
4. McConkey D., Choi W., Marquis L., et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastas Rev 28 (2009) 335
5. Eichberger T., Sander V., Schnidar H., et al. Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 87 (2006) 616
6. Fan H., Oro A.E., Scott M.P., et al. Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med 3 (1997) 788
7. Taipale J., Chen J.K., Cooper M.K., et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406 (2000) 1005
8. Zurawel R.H., Allen C., Chiappa S., et al. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 27 (2000) 44
9. Tsai Y.C., Nichols P.W., Hiti A.L., et al. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res 50 (1990) 44
10. Keeler R.F. Cyclopamine and related steroidal alkaloid teratogens: their occurrence, structural relationship, and biologic effects. Lipids 13 (1978) 708
11. Chen L.M., Wang C., Chen M., et al. Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation. Am J Physiol Renal Physiol 291 (2006) F567
12. Yu X., Zhan X., D'Costa J., et al. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther 7 (2003) 827
13. Cooper M.K., Porter J.A., Young K.E., et al. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280 (1998) 1603
14. Roessler E., Ermilov A.N., Grange D.K., et al. A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. Hum Mol Genet 14 (2005) 2181
15. Stanton B.Z., and Peng L.F. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst 6 (2010) 44
16. Berman D.M., Karhadkar S.S., Maitra A., et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425 (2003) 846
17. Thievessen I., Wolter M., Prior A., et al. Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. J Cell Physiol 203 (2005) 372
18. Ahlering T.E., Dubeau L., and Jones P.A. A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res 47 (1987) 6660
19. Dinney C.P., Fishbeck R., Singh R.K., et al. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 154 (1995) 1532
20. Grossman H.B., Wedemeyer G., Ren L., et al. Improved growth of human urothelial carcinoma cell cultures. J Urol 136 (1986) 953
21. Kasper M., Regl G., Frischauf A.M., et al. GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur J Cancer 42 (2006) 437
22. Eichberger T., Kaser A., Pixner C., et al. GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells. J Biol Chem 283 (2008) 12426
23. Kump E., Ji J., Wernli M., et al. Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis. Oncogene 27 (2008) 3856
24. Regl G., Kasper M., Schnidar H., et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 64 (2004) 7724
25. Katoh M., and Katoh M. Integrative genomic analyses of ZEB2: transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB. Int J Oncol 34 (2009) 1737
26. Kim Y., Yoon J.W., Xiao X., et al. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells. Cancer Res 67 (2007) 3583
27. Narita S., So A., Ettinger S., et al. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin Cancer Res 14 (2008) 5769
28. Lauth M., and Toftgard R. Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle 6 (2007) 2458
29. Hung T.T., Wang H., Kingsley E.A., et al. Molecular profiling of bladder cancer: involvement of the TGF-beta pathway in bladder cancer progression. Cancer Lett 265 (2008) 27
30. Oxford G., and Theodorescu D. The role of Ras superfamily proteins in bladder cancer progression. J Urol 170 (2003) 1987